Research Advances of Immunotherapy for Follicular Lymphoma --Review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 627-630, 2022.
Article
in Zh
| WPRIM
| ID: wpr-928765
Responsible library:
WPRO
ABSTRACT
Follicular lymphoma is an indolent malignant tumor originating from lymph nodes and lymphoid tissues, which may affect the patients' quality of survival due to the recurrence and progression. In recent years, with the deepening understand of the molecular biology and signaling pathways, many new targeted drugs for follicular lymphoma have been discovered, such as monoclonal antibodies, checkpoint inhibitors, epigenetic regulation related targeted therapies and signaling pathway inhibitors. In this review, the new progress of immunotherapy for follicular lymphoma is summarized briefly.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Lymphoma, Follicular
/
Epigenesis, Genetic
/
Immunologic Factors
/
Immunotherapy
/
Antineoplastic Agents
Limits:
Humans
Language:
Zh
Journal:
Journal of Experimental Hematology
Year:
2022
Type:
Article